CFG
ABBV icon

Copley Financial Group’s AbbVie ABBV Stock Holding History

Copley Financial Group’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$275K Sell
1,092
-673
-38% -$145K 0.17% 88
2026
Q1 		$384K Sell
1,765
-124
-7% -$27.5K 0.23% 76
2025
Q4 		$432K Sell
1,889
-256
-12% -$58.3K 0.27% 60
2025
Q3 		$497K Sell
2,145
-105
-5% -$21.4K 0.34% 50
2025
Q2 		$418K Sell
2,250
-244
-10% -$45.3K 0.31% 67
2025
Q1 		$523K Sell
2,494
-100
-4% -$19.4K 0.4% 53
2024
Q4 		$461K Buy
2,594
+119
+5% +$21.9K 0.35% 64
2024
Q3 		$489K Buy
+2,475
New +$462K 0.44% 52

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Copley Financial Group's ABBV Position: Q2 2026 in Review

Copley Financial Group reduced its AbbVie (ABBV) stake by 38% in Q2 2026, selling an estimated $145K and leaving 1,092 shares worth $275K. The position accounts for 0.17% of the portfolio, ranked #88.

Copley Financial Group first reported a position in ABBV in Q3 2024 and has held it in 8 quarters since. The position peaked at $523K in Q1 2025. 4,215 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Copley Financial Group held 1,092 shares of AbbVie worth $275K as of Q2 2026.
  • Copley Financial Group sold 673 AbbVie shares in Q2 2026, an estimated $145K.
  • AbbVie made up 0.17% of Copley Financial Group's portfolio in Q2 2026, its #88 holding.
  • Copley Financial Group first reported a position in AbbVie in Q3 2024 and has held it in 8 quarters since.
  • Copley Financial Group's AbbVie position peaked at $523K in Q1 2025.
  • 4,215 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Copley Financial Group's 13F filing for Q2 2026, filed 11 Aug 2026.